David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 56
Out of 4,668 analysts
1085
Total ratings
65.4%
Success rate
33.9%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $37 | $32.83 | +12.70% | 1 | Aug 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $641 → $824 | $826.64 | -0.32% | 59 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $4 | $1.78 | +124.72% | 10 | Aug 11, 2026 | |
| HALO Halozyme Therapeutics | Upgraded: Buy | $110 | $106.12 | +3.66% | 38 | Aug 7, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | n/a | $1,244.40 | - | 120 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $265 → $276 | $267.37 | +3.23% | 54 | Jul 17, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $104.86 | - | 15 | Jun 2, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | n/a | $56.69 | - | 33 | May 27, 2026 | |
| IMA ImageneBio | Maintained: Buy | $30 → $24 | $5.61 | +327.81% | 2 | May 8, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $46 | $41.90 | +9.79% | 1 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $433.73 | - | 42 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $65.47 | -8.35% | 71 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $261.83 | - | 72 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $540.26 | -2.82% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $77.79 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $36.84 | -13.14% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $27.79 | -6.44% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.34 | - | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.15 | - | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.05 | - | 13 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.75 | n/a | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $16.95 | n/a | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $44 | $50.52 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $27 → $23 | $133.32 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $55.04 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.14 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.22 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 | $143.44 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.31 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.74 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $248.70 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $20 → $22 | $35.18 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $148.99 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $16.12 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $45 | $13.70 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48.31 | $9.41 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $22 | $48.02 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $9 | $36.81 | n/a | 29 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $167 → $41 | $23.56 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $167 → $174 | $75.02 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $60.58 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $3 | $17.90 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $314.69 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $142.07 | n/a | 3 | Sep 21, 2012 |
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $32.83
Upside: +12.70%
Regeneron Pharmaceuticals
Aug 17, 2026
Maintained: Hold
Price Target: $641 → $824
Current: $826.64
Upside: -0.32%
Tenax Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $4
Current: $1.78
Upside: +124.72%
Halozyme Therapeutics
Aug 7, 2026
Upgraded: Buy
Price Target: $110
Current: $106.12
Upside: +3.66%
Eli Lilly and Company
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $1,244.40
Upside: -
Johnson & Johnson
Jul 17, 2026
Maintained: Buy
Price Target: $265 → $276
Current: $267.37
Upside: +3.23%
Oruka Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $104.86
Upside: -
AnaptysBio
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $56.69
Upside: -
ImageneBio
May 8, 2026
Maintained: Buy
Price Target: $30 → $24
Current: $5.61
Upside: +327.81%
First Tracks Biotherapeutics
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $41.90
Upside: +9.79%
Jan 13, 2026
Maintained: Hold
Price Target: n/a
Current: $433.73
Upside: -
Jan 13, 2026
Maintained: Buy
Price Target: $60
Current: $65.47
Upside: -8.35%
Jan 13, 2026
Maintained: Buy
Price Target: n/a
Current: $261.83
Upside: -
Dec 29, 2025
Maintained: Buy
Price Target: $525
Current: $540.26
Upside: -2.82%
Dec 24, 2025
Maintained: Buy
Price Target: n/a
Current: $77.79
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $36.84
Upside: -13.14%
Dec 9, 2025
Maintained: Hold
Price Target: $26
Current: $27.79
Upside: -6.44%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $61.34
Upside: -
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $45.15
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: n/a
Current: $36.05
Upside: -
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.75
Upside: n/a
Aug 13, 2025
Maintained: Hold
Price Target: $13
Current: $16.95
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $60 → $44
Current: $50.52
Upside: n/a
Apr 16, 2025
Maintained: Sell
Price Target: $27 → $23
Current: $133.32
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $55.04
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.14
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $26.22
Upside: n/a
Apr 28, 2023
Maintained: Hold
Price Target: $91
Current: $143.44
Upside: n/a
Mar 14, 2023
Maintained: Buy
Price Target: n/a
Current: $11.31
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.74
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $248.70
Upside: n/a
May 13, 2021
Maintained: Sell
Price Target: $20 → $22
Current: $35.18
Upside: n/a
Apr 1, 2021
Maintained: Buy
Price Target: $90
Current: $148.99
Upside: n/a
Mar 10, 2021
Maintained: Hold
Price Target: $18 → $16
Current: $16.12
Upside: n/a
Mar 5, 2021
Maintained: Hold
Price Target: $53 → $45
Current: $13.70
Upside: n/a
Feb 26, 2021
Maintained: Hold
Price Target: $48.31
Current: $9.41
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $16 → $22
Current: $48.02
Upside: n/a
Dec 21, 2020
Maintained: Sell
Price Target: $8 → $9
Current: $36.81
Upside: n/a
Nov 23, 2020
Maintained: Buy
Price Target: $167 → $41
Current: $23.56
Upside: n/a
Nov 13, 2020
Maintained: Hold
Price Target: $167 → $174
Current: $75.02
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $60.58
Upside: n/a
Apr 2, 2020
Maintained: Hold
Price Target: $18 → $3
Current: $17.90
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $314.69
Upside: n/a
Sep 21, 2012
Maintained: Buy
Price Target: $36
Current: $142.07
Upside: n/a